|
|
Office Locations:
|
150 Union Square Drive
New Hope, PA 18938
Phone: 908-524-1188
Fax: 917-922-5458
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Orchestra Medical Ventures (formerly Accelerated Technologies Partners) is an investment firm that employs a proprietary and innovative strategy to create, build and invest in medical technology companies. The firm invests in companies that show promise in generating substantial clinical value and superior investor returns. Orchestra's investment strategy is to 1) Align experienced experts; 2) Identify and analyze requirements of clinical sectors; 3) Create investment opportunities for clinical needs; 4) Leverage capital; and 5) Realize superior returns. Since 2000, the Orchestra Strategy has been successfully pursued through a predecessor medical device accelerator called Accelerated Technologies, Inc. (ATI), which continues to be operated today by Orchestra.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
